Acid Sphingomyelinase Deficiency (ASMD) Market is segmented By Therapy (XENPOZYME (olipudase alfa), Other Enzyme Replacement Therapies (ERT)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.